The global gastrointestinal drugs market, valued at $62.57 billion in 2025, is poised for significant growth fueled by rising prevalence of GI disorders and advancements in drug delivery. Learn more about market trends, key players (Takeda, AstraZeneca, Pfizer), and future projections in our comprehensive analysis.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.